HUMAN PRESCRIPTION DRUG: 55513-132

Brand Name: Kanjinti

Generic Name: trastuzumab-anns

Primary Class: HER2/Neu/cerbB2 Antagonists [MoA]

SPL Set ID: 9a94f5b2-b84e-4987-8ea1-c4346db5a5fa view on Dailymed | RXCUI: 2174804

Manufacturer Name: Amgen, Inc

Associated Package NDCs
Package NDC Description
55513-132-01 1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-01) / 20 mL in 1 VIAL, MULTI-DOSE
55513-132-21 1 VIAL, MULTI-DOSE in 1 CARTON (55513-132-21) / 20 mL in 1 VIAL, MULTI-DOSE